Accuray Incorporated logo
Accuray Incorporated ARAY
$ 0.33 16.41%

Quarterly report 2026-Q3
added 05-06-2026

report update icon

Accuray Incorporated Balance Sheet 2011-2026 | ARAY

Annual Balance Sheet Accuray Incorporated

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Net Debt

73.7 M 102 M 86.3 M 91.7 M 60 M 87.6 M 83 M 48 M 92.5 M 90.6 M 123 M 103 M 125 M -64 M -95.9 M - -

Long Term Debt

124 M 164 M 172 M 172 M 170 M 189 M 160 M 131 M 51.5 M 171 M 203 M 196 M 199 M 79.5 M - - -

Long Term Debt Current

7.38 M 6.22 M 4.15 M 8.57 M 8.17 M 8.22 M - - 113 M 39.9 M - - - - - - -

Total Non Current Liabilities

- - - - - - 196 M 161 M 75.4 M 199 M 224 M 212 M 213 M 95.1 M 12.4 M - -

Total Current Liabilities

193 M 195 M 199 M 209 M 192 M 182 M 192 M 169 M 284 M 210 M 170 M 185 M 156 M 174 M - - -

Total Liabilities

389 M 424 M 426 M 420 M 411 M 427 M 388 M 330 M 360 M 409 M 394 M 397 M 369 M 269 M 215 M - -

Deferred Revenue

82.3 M 71.6 M 72.2 M 75.4 M 81.7 M 106 M 98.7 M 98.3 M 105 M 114 M 116 M 112 M 105 M 101 M 94 M - -

Retained Earnings

-519 M -518 M -502 M -493 M -488 M -482 M -486 M -474 M -450 M -421 M -395 M -355 M -320 M -216 M -144 M - -

Total Assets

470 M 469 M 479 M 473 M 480 M 491 M 438 M 379 M 406 M 469 M 470 M 495 M 476 M 473 M 456 M - -

Cash and Cash Equivalents

57.4 M 68.6 M 89.4 M 88.7 M 118 M 110 M 76.8 M 83.1 M 72.1 M 120 M 79.6 M 92.3 M 73.3 M 144 M 95.9 M 45.4 M 36.8 M

Book Value

81.2 M 45.1 M 53.7 M 53.2 M 68.8 M 63.6 M 49.9 M 48.6 M 46.5 M 59.7 M 75.8 M 98.5 M 107 M 204 M 240 M - -

Total Shareholders Equity

81.2 M 45.1 M 53.7 M 53.2 M 68.8 M 63.6 M 49.9 M 48.6 M 46.5 M 59.7 M 75.8 M 98.5 M 107 M 204 M 230 M 170 M 154 M

All numbers in USD currency

Quarterly Balance Sheet Accuray Incorporated

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

134 M 125 M 127 M 125 M 127 M 124 M 166 M 168 M 162 M 164 M 166 M 168 M 170 M 172 M 173 M 174 M 171 M 172 M 173 M 174 M 194 M 170 M 170 M 168 M 174 M 189 M 189 M 184 M 188 M 160 M 160 M 137 M 129 M 131 M 131 M 130 M 119 M 51.5 M 51.5 M 167 M 172 M 171 M 171 M 110 M 110 M 200 M 203 M 199 M 197 M 196 M 196 M 201 M 200 M 199 M 199 M 81.6 M 80.5 M 79.5 M 79.5 M 77.5 M 76.6 M - -

Total Liabilities

406 M 395 M 395 M 395 M 395 M 389 M 435 M 430 M 428 M 424 M 421 M 429 M 426 M 426 M 421 M 417 M 419 M 420 M 418 M 425 M 430 M 411 M 411 M 400 M 397 M 427 M 427 M 423 M 423 M 388 M 388 M 340 M 322 M 330 M 330 M 365 M 345 M 360 M 360 M 369 M 369 M 409 M 409 M 412 M 398 M 391 M 394 M 392 M 379 M 397 M 397 M 390 M 378 M 369 M 369 M 265 M 269 M 269 M 269 M 261 M 261 M 215 M 215 M

Deferred Revenue

78.9 M 79 M 79.6 M 79 M 79.6 M 82.3 M 81.8 M 72.1 M 81.3 M 71.6 M 73.7 M 77.4 M 71.8 M 72.2 M 73.1 M 72.7 M 69.9 M 75.4 M 76.7 M 76.6 M 78.9 M 81.7 M 81.7 M 80.9 M 81.3 M 83.2 M 83.2 M 79.6 M 79.6 M 78.3 M 78.3 M 72.7 M 72.3 M 75.4 M 75.5 M 80 M 80.3 M 87.8 M 87.8 M 91 M 91.3 M 92.1 M 92.1 M 94.4 M 90.7 M 96.8 M 96.8 M 92.5 M 89.3 M 92.1 M 92.1 M 96.5 M 88.4 M 86.9 M 86.9 M 87.3 M 77.8 M 83.1 M 83.1 M 83.6 M 74.4 M 68.2 M 68.2 M

Retained Earnings

-567 M -555 M -541 M -555 M -541 M -519 M -520 M -519 M -522 M -518 M -521 M -515 M -505 M -502 M -500 M -500 M -498 M -493 M -489 M -488 M -488 M -488 M -488 M -477 M -481 M -482 M -482 M -484 M -495 M -486 M -486 M -483 M -478 M -474 M -474 M -464 M -460 M -450 M -450 M -440 M -431 M -421 M -421 M -414 M -408 M -395 M -395 M -387 M -377 M -355 M -355 M -341 M -335 M -320 M -320 M -270 M -241 M -216 M -216 M -181 M -171 M -144 M -144 M

Total Assets

448 M 448 M 457 M 448 M 457 M 470 M 484 M 478 M 473 M 469 M 463 M 476 M 477 M 479 M 476 M 469 M 466 M 473 M 469 M 476 M 476 M 480 M 480 M 478 M 465 M 491 M 491 M 479 M 464 M 438 M 438 M 386 M 369 M 379 M 379 M 414 M 394 M 406 M 406 M 415 M 423 M 469 M 469 M 473 M 462 M 467 M 470 M 468 M 460 M 495 M 495 M 485 M 473 M 476 M 476 M 416 M 438 M 473 M 473 M 492 M 500 M 456 M 456 M

Cash and Cash Equivalents

38.1 M 41.3 M 63.3 M 41.3 M 63.3 M 57.4 M 77.8 M 62.6 M 61.1 M 68.6 M 62.2 M 74.5 M 78.7 M 89.4 M 90.8 M 69.2 M 82.4 M 88.7 M 99.3 M 125 M 106 M 118 M 116 M 107 M 90 M 108 M 108 M 96.4 M 80.9 M 76.8 M 76.8 M 59.4 M 68.5 M 83.1 M 83.1 M 79.5 M 67.9 M 72.1 M 72.1 M 69.5 M 83.6 M 120 M 120 M 88.5 M 85.6 M 88.5 M 85.6 M 97.3 M 107 M 97.3 M 107 M 70.4 M 62.4 M 70.4 M 62.4 M 94.8 M 122 M 94.8 M 122 M 148 M 140 M 148 M 140 M

Book Value

41.7 M 53.4 M 61.9 M 53.4 M 61.9 M 81.2 M 49.6 M 47.9 M 45.2 M 45.1 M 41.1 M 47.7 M 50.9 M 53.7 M 54.7 M 51.7 M 47 M 53.2 M 51.6 M 51 M 45.8 M 68.8 M 68.8 M 77.8 M 67.4 M 63.6 M 63.6 M 56 M 41 M 49.9 M 49.9 M 46.1 M 47.1 M 48.6 M 48.6 M 49.1 M 48.6 M 46.5 M 46.5 M 46.7 M 53.4 M 59.7 M 59.7 M 60.9 M 64.1 M 75.8 M 75.8 M 75.9 M 80.5 M 98.5 M 98.5 M 95.2 M 94.7 M 107 M 107 M 151 M 169 M 204 M 204 M 231 M 239 M 240 M 240 M

Total Shareholders Equity

41.7 M 53.4 M 61.9 M 53.4 M 61.9 M 81.2 M 49.6 M 47.9 M 45.2 M 45.1 M 41.1 M 47.7 M 50.9 M 53.7 M 54.7 M 51.7 M 47 M 53.2 M 51.6 M 51 M 45.8 M 68.8 M 45.8 M 77.8 M 77.8 M 77.8 M 67.4 M 56 M 56 M 56 M 41 M 46.1 M 46.1 M 46.1 M 47.1 M 49.1 M 48.6 M 49.1 M 48.6 M 46.7 M 53.4 M 59.7 M 59.7 M 60.9 M 64.1 M 75.8 M 75.8 M 75.9 M 80.5 M 98.5 M 95.8 M 95.2 M 94.7 M 107 M 107 M 151 M 173 M 204 M 196 M 224 M 230 M 240 M 230 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Accuray Incorporated, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.2 0.27 % $ 317 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 8.24 0.24 % $ 1.24 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.25 -1.62 % $ 159 M franceFrance
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
LENSAR LENSAR
LNSR
$ 5.88 1.38 % $ 70.3 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.31 6.94 % $ 50.9 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.47 -0.57 % $ 29.2 M usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.79 4.12 % $ 560 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 18.5 1.48 % $ 434 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 73.71 1.08 % $ 4.02 B britainBritain
Delcath Systems Delcath Systems
DCTH
$ 11.23 3.5 % $ 402 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.0 -4.76 % $ 16.9 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.54 14.93 % $ 62.7 M usaUSA
Electromed Electromed
ELMD
$ 37.74 -1.64 % $ 319 M usaUSA
Myomo Myomo
MYO
$ 0.91 4.17 % $ 38.1 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.39 6.94 % $ 1.08 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 12.15 0.5 % $ 481 M curacaoCuracao
Sintx Technologies Sintx Technologies
SINT
$ 2.21 0.45 % $ 6.13 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.92 2.82 % $ 209 M canadaCanada
Globus Medical Globus Medical
GMED
$ 84.03 5.13 % $ 11.4 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 156.59 1.28 % $ 11 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 37.01 2.29 % $ 1.15 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 44.14 3.79 % $ 1.3 B usaUSA
TransMedics Group TransMedics Group
TMDX
$ 68.0 2.83 % $ 2.31 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 91.49 1.16 % $ 3.18 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 82.97 0.99 % $ 48.5 B usaUSA